Michel James Voigt - Mar 4, 2024 Form 4 Insider Report for MERIT MEDICAL SYSTEMS INC (MMSI)

Role
CHIEF HUMAN RESOURCES OFFICER
Signature
/s/ Brian G. Lloyd, Attorney-in-Fact
Stock symbol
MMSI
Transactions as of
Mar 4, 2024
Transactions value $
-$201,221
Form type
4
Date filed
3/6/2024, 08:21 PM
Previous filing
Mar 15, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction MMSI Common Stock, No Par Value Award $0 +5.23K +1015.15% $0.00 5.74K Mar 4, 2024 Direct F2
transaction MMSI Common Stock, No Par Value Award $0 +7.11K +123.8% $0.00 12.9K Mar 4, 2024 Direct F3
transaction MMSI Common Stock, No Par Value Tax liability -$201K -2.63K -20.46% $76.51 10.2K Mar 4, 2024 Direct F4
transaction MMSI Common Stock, No Par Value Gift $0 -315 -3.08% $0.00 9.91K Mar 6, 2024 Direct
holding MMSI Common Stock, No Par Value 15 Mar 4, 2024 By 401(k) Plan F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding MMSI Non-qualified stock options (right to buy) 9.68K Mar 4, 2024 Common Stock 9.68K $56.25 Direct F5
holding MMSI Non-qualified stock options (right to buy) 8.09K Mar 4, 2024 Common Stock 8.09K $65.03 Direct F6
holding MMSI Non-qualified stock options (right to buy) 13.6K Mar 4, 2024 Common Stock 13.6K $70.58 Direct F7
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents plan holdings as of 03/04/2024.
F2 Represents a grant of restricted stock units ("RSUs"). The RSUs vest in four equal annual installments on each of the first four anniversaries of the grant date, subject to the Reporting Person's continued service through the applicable vesting date. Each RSU represents the contingent right to receive one share of Common Stock upon vesting.
F3 These shares were acquired upon a determination of the Company's Compensation and Talent Development Committee that certain conditions had been met for the issuance of such shares pursuant to performance stock units that were granted on 03/19/2021.
F4 Reflects shares of Common Stock surrendered by the Reporting Person to satisfy tax withholding obligations in connection with the issuance of the performance stock units. These shares were not sold in an open-market transaction,
F5 Becomes exercisable in equal annual installments of 25% commencing on 03/19/2022.
F6 Becomes exercisable in equal annual installments of 25% commencing on 02/28/2023.
F7 Becomes exercisable in equal annual installments of 25% commencing on 02/28/2024.